Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(50%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(2)

Detailed Status

Completed2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed250%
terminated250%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Sepraspray™ Laparoscopic Myomectomy Study

NCT00624390
completednot_applicable

Manageability and Safety Assessment of Sepraspray in Abdominal Surgery.

NCT00813397
terminatednot_applicable

Evaluation of the Safety and Effectiveness of Sepraspray™ in Reducing Post-surgical Adhesions

NCT00665730
terminatednot_applicable

Evaluation of the Safety of Sepraspray in Open Abdominal Surgery

NCT00778479

Clinical Trials (4)

Showing 4 of 4 trials
NCT00624390Not Applicable

Sepraspray™ Laparoscopic Myomectomy Study

Completed
NCT00813397Not Applicable

Manageability and Safety Assessment of Sepraspray in Abdominal Surgery.

Completed
NCT00665730Not Applicable

Evaluation of the Safety and Effectiveness of Sepraspray™ in Reducing Post-surgical Adhesions

Terminated
NCT00778479Not Applicable

Evaluation of the Safety of Sepraspray in Open Abdominal Surgery

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4